Ovariectomy uncouples lifespan from metabolic health and reveals a sex-hormone-dependent role of hepatic mTORC2 in aging

Abstract
Introduction
Results
Discussion
Materials and methods
Data availability
References
Article and author information
Metrics

Abstract

Inhibition of mTOR (mechanistic Target Of Rapamycin) signaling by rapamycin promotes healthspan and longevity more strongly in females than males, perhaps because inhibition of hepatic mTORC2 (mTOR Complex 2) specifically reduces the lifespan of males. Here, we demonstrate using gonadectomy that the sex-specific impact of reduced hepatic mTORC2 is not reversed by depletion of sex hormones. Intriguingly, we find that ovariectomy uncouples lifespan from metabolic health, with ovariectomized females having improved survival despite paradoxically having increased adiposity and decreased control of blood glucose levels. Further, ovariectomy unexpectedly promotes midlife survival of female mice lacking hepatic mTORC2, significantly increasing the survival of those mice that do not develop cancer. In addition to identifying a sex hormone-dependent role for hepatic mTORC2 in female longevity, our results demonstrate that metabolic health is not inextricably linked to lifespan in mammals, and highlight the importance of evaluating healthspan in mammalian longevity studies.

Introduction

The high frequency and co-morbidity of age-related disease in the aged limits the benefits that can be achieved by targeting them individually. An alternative approach, which could simultaneously treat or prevent many age-related diseases, is to target the aging process itself (Kennedy et al., 2014). However, extending lifespan without also extending healthspan is generally considered undesirable (Kaeberlein, 2018), and not all geroprotective interventions may necessarily improve healthspan. Indeed, a recent study in C. elegans found that lifespan and healthspan can be uncoupled in this organism (Bansal et al., 2015). Thus, there is a clear need to assess healthspan in mammalian longevity studies.

The mechanistic Target Of Rapamycin (mTOR) is a serine/threonine protein kinase that serves as a central regulator of metabolism and aging and is found in two distinct protein complexes, mTOR Complex 1 (mTORC1) and mTORC2 (Kennedy and Lamming, 2016). mTORC1 is acutely sensitive to the action of the FDA-approved pharmaceutical rapamycin, and inhibition of mTORC1, either genetically or by rapamycin, extends lifespan and healthspan in model organisms ranging from yeast to mice (Arriola Apelo et al., 2016b; Bitto et al., 2016; Harrison et al., 2009; Kaeberlein et al., 2005; Kapahi et al., 2004; Medvedik et al., 2007; Powers et al., 2006; Vellai et al., 2003). Pharmaceutical or genetic inhibition of mTOR signaling tends to extend female lifespan to a greater extent than that of males (Lamming, 2014; Miller et al., 2014).

However, chronic treatment of mice with rapamycin induces a variety of metabolic side effects. We and others have shown that many of these effects are mediated by ‘off-target’ inhibition of mTORC2 (Arriola Apelo et al., 2016a; Dumas and Lamming, 2020; Kleinert et al., 2017; Kleinert et al., 2014; Lamming et al., 2012; Sarbassov et al., 2006; Schreiber et al., 2019; Schreiber et al., 2015). These studies highlighted an important gap in our knowledge – namely, the contribution of decreased mTORC2 signaling to the effect of rapamycin on lifespan. Studies in C. elegans and D. melanogaster have not convincingly addressed this question, as reduced mTORC2 signaling can be beneficial or detrimental in C. elegans depending on the tissue and diet, while overexpression of Rictor, which encodes an essential protein component of mTORC2, extends the lifespan of flies (Chang et al., 2019; Mizunuma et al., 2014; Robida-Stubbs et al., 2012; Soukas et al., 2009).

Deletion of Rictor in several distinct tissues or inducibly in the whole body of adult mice negatively impacts survival (Chellappa et al., 2019; Lamming et al., 2014b; Yu et al., 2019). Intriguingly, loss of hepatic mTORC2 specifically reduces male lifespan, with no effect of liver-specific deletion of Rictor on the lifespan of female mice (Lamming et al., 2014b). This difference between males and females was not due to sex-based differences in the efficiency of Rictor deletion (Lamming et al., 2014b). This sex-specific effect of hepatic mTORC2 inhibition may help to explain why rapamycin has a stronger effect on female lifespan (Lamming, 2014; Miller et al., 2014). Many sexually dimorphic responses, including to geroprotective interventions, are mediated in part by gonadal sex hormones (Garratt et al., 2017; Garratt et al., 2018). We hypothesized that gonadectomy would either protect male mice from the loss of hepatic Rictor, or sensitize female mice to the loss of hepatic Rictor.

We therefore examined how mice lacking hepatic Rictor responded to gonadectomy. We find that the male-specific negative impact of Rictor loss on overall survival persists following gonadectomy. While pre-pubertal gonadectomy negatively impacted the metabolic health of both liver Rictor knockout (L-RKO) mice and their wild-type littermates, it did not negatively impact survival, with ovariectomized mice in particular surviving longer than sham-surgery controls. Intriguingly, while as we expected based on our prior results, the overall survival of sham-surgery L-RKO female mice was not statistically different from that of female wild type controls, there was an apparent reduction in the survival of L-RKO Sham females between 400–800 days of age that was not observed in ovariectomized L-RKO mice. An in-depth analysis suggests that pre-pubertal ovariectomy promotes the midlife survival of female mice lacking hepatic Rictor, through protection from a non-cancer related cause of death. We conclude that there is a sex-specific role for hepatic mTORC2 in survival that is dependent upon sex hormones, and that ovariectomy uncouples metabolic health and longevity.

Results

Depletion of hepatic Rictor reduces the overall lifespan of male mice independently of sex hormones

We castrated male L-RKO mice and their wild-type littermates, and ovariectomized female L-RKO mice and their wild-type littermates, between 3 and 4 weeks of age; sham surgeries were performed on mice of both sexes and genotypes to control for any effects of the surgical procedures. We examined the longevity of all 8 groups of animals, separately analyzing females and males due to the expected sexually dimorphic effects. While cause of death analysis is difficult in mice, we performed gross necropsy on as many animals as possible, noting the presence or absence of observable cancers. As we expected for C57BL/6J mice (Brayton et al., 2012), we observed cancer in approximately half of the necropsied animals. There was no statistically significant difference in the frequency of observed cancer at necropsy between groups of male mice (chi-square test, p=0.06), although cancer was identified much more frequently in L-RKO CAST mice than in any other group of male mice (Figure 1—figure supplement 1).

We initially stratified our analysis of mice by the presence or absence of observable cancers at necropsy. We performed a Cox regression analysis to identify the overall effects of genotype and surgery, and then calculated the corrected two-sided log-rank sum p-value comparing individual curves for those effects identified as significant in the regression analysis. Intriguingly, there was no effect of hepatic Rictor deletion on the overall longevity of male mice that died with observed cancer (Figure 1A). In contrast, there was a dramatic effect of Rictor loss on the survival of male mice (HR = 4.84, p=0.0014) in which cancer was not observed during our gross necropsy (Figure 1B). We observed no overall effect of gonadectomy in either group of mice.

Figure 1 with 1 supplement see all

Download asset Open asset

Deletion of hepatic *Rictor* impairs male survival independently of sex hormones.

(A) Kaplan-Meier plot of the survival of male mice in which cancer was observed during gross necropsy (N = 38 male mice; WT Sham 5, L-RKO Sham 9, WT CAST 10, L-RKO CAST 14; Supplementary file 1). (B) Kaplan-Meier plot of the survival of male mice in which cancer was not observed during gross necropsy (N = 32 male mice; WT Sham 7, L-RKO Sham 11, WT CAST 11, L-RKO CAST 3; Supplementary file 1). (C) Kaplan-Meier plot of the survival of male mice lacking hepatic *Rictor* (L-RKO) and their wild-type (WT) littermates. All mice were subjected to gonadectomy (CAST) or Sham surgery at 3 weeks of age (N = 105 male mice; WT Sham 23, L-RKO Sham 27, WT CAST 29, L-RKO CAST 26; Supplementary file 1). (**A–C**) The overall effect of genotype (RKO), gonadectomy (CAST), and the interaction was determined using a Cox-proportional hazards test (HR, hazard ratio). The two-sided log-rank sum p-value was then calculated comparing individual curves for effects identified as significant in the regression analysis, and corrected for multiple comparisons (Holm-Sidak).

Looking at the survival of all of the male mice (Figure 1C), in agreement with our previous study (Lamming et al., 2014b) we observed an overall negative effect of hepatic Rictor loss on the survival of male mice, with deletion of Rictor leading to an increased hazard ratio (HR (RKO) = 1.75, p=0.01), and no overall effect of castration. This effect was driven in part by a statistically significant decrease (log-rank p=0.028) in the lifespan of intact male L-RKO mice relative to intact wild-type mice, with a 13.7% decrease in median lifespan. We also observed a 10% decrease in median lifespan in castrated male L-RKO relative to castrated male wild-type mice; these lifespan curves were not distinguishable (log-rank p=0.337). The almost complete overlap of the L-RKO Sham and L-RKO CAST survival curves demonstrate that castration does not rescue the lifespan defect of male mice lacking hepatic Rictor.

Depletion of hepatic Rictor impairs midlife survival of female mice, a defect rescued by ovariectomy

There was no statistically significant difference in the frequency of observed cancer at necropsy between groups of female mice (chi-square test, p=0.78) (Figure 2—figure supplement 1), and we observed no effect of hepatic Rictor deletion on the overall longevity of female mice that died with observed cancer (Figure 2A). However, to our great surprise, there was a dramatic effect of Rictor loss on the survival of female mice (HR = 6.67, p=0.00084) in which cancer was not observed during our gross necropsy (Figure 2B). Although there was no overall effect of gonadectomy, we observed a strong interaction between the effect of Rictor loss and ovariectomy (p=0.014), and the survival curves of L-RKO OVX mice overlap the survival curves of WT Sham and WT OVX, leading us to interpret this interaction as demonstrating a strong protective effect of ovariectomy against a non-cancer related cause of death in mice lacking hepatic Rictor.

Figure 2 with 1 supplement see all

Download asset Open asset

Ovariectomy protects female mice lacking hepatic *Rictor* during midlife.

(A) Kaplan-Meier plot of the survival of female mice in which cancer was observed during gross necropsy (N = 37 female mice; WT Sham 11, L-RKO Sham 9, WT OVX 10, L-RKO OVX 7; Supplementary file 1). (B) Kaplan-Meier plot of the survival of female mice in which cancer was not observed during gross necropsy (N = 36 female mice; WT Sham 11, L-RKO Sham 8, WT OVX 7, L-RKO OVX 10; Supplementary file 1). (C) Kaplan-Meier plot of the survival of female mice lacking hepatic *Rictor* (L-RKO) and their wild-type (WT) littermates. All mice were subjected to gonadectomy (OVX) or Sham surgery at 3 weeks of age (N = 115 female mice; WT Sham 31, L-RKO Sham 29, WT OVX 27, L-RKO OVX 28; Supplementary file 1). (**A–C**) The overall effect of genotype (RKO), gonadectomy (OVX), and the interaction was determined using a Cox-proportional hazards test (HR, hazard ratio). The two-sided log-rank sum p-value was then calculated comparing individual curves for effects identified as significant in the regression analysis, and corrected for multiple comparisons (Holm-Sidak).

Despite this strong effect, when we looked at the total population of female mice in our study, the negative effect of Rictor loss on Sham-treated female mice was masked, and in agreement with our previous study (Lamming et al., 2014b) there was no overall negative effect of Rictor loss on survival (Figure 2C). There was also no difference between thesurvival of WT Sham and WT L-RKO female mice (p=0.153, Wilcoxon rank sum). We did however find an overall protective effect of pre-pubertal ovariectomy (HR (OVX) = 0.66, p=0.05). Inspection of the Kaplan-Meir plots and our results in Figure 2B lead us to conclude that this effect is largely driven by the protective effect of pre-pubertal ovariectomy on the midlife survival of female L-RKO mice. Finally, ovariectomized L-RKO female mice had a 17% increase in median lifespan relative to sham L-RKO females, due to a divergence of these lifespan curves between 400 and 800 days of age. This difference was statistically significant (p=0.025) by the Wilcoxon rank-sum test, which does not assume proportional hazards.

Ovariectomy impairs the metabolic health of mice

During the course of our longevity study, we tracked weight and body composition (Figure 3A–F). Gonadectomy had a profound effect on the weight and body composition of wild-type mice, with castration reducing the weight of wild-type males due to a decrease in lean mass (Figure 3A and C), and with ovariectomy increasing the weight of wild-type females due an increase in fat mass (Figure 3B and F). Intriguingly, male L-RKO Sham mice weighed substantially less than their wild-type Sham littermates due to an overall decrease in fat mass (Figure 3A and E); however, no differences in fat mass due to genotype were observed in females (Figure 3F). Castration rescued the decreased adipose mass of L-RKO male mice, while not affecting fat mass in wild-type mice (Figure 3E).

Figure 3

Download asset Open asset

Gonadectomy affects weight and body composition, and rescues a male-specific effect of hepatic *Rictor* deletion on fat mass.

(**A, B**) The weight of A) male and (B) female mice lacking hepatic *Rictor* (L-RKO) and their wild-type (WT) littermates was tracked starting at 3 months of age (n varies by month; maximum female N = 22–26 mice/group, maximum male N = 20–23 mice/group). (**C–F**) The lean mass (**C, D**) and fat mass (**E, F**) of mice was determined every 4 months starting at 8 months of age (n varies by month; max female N = 9–17/group; max male N = 12–17/group). p-values for the overall effect of genotype (GT) or surgical treatment (Surgery) represent the p-value from pairwise two-way ANOVA testing. Error bars represent SEM.

In order to gain insight into the alterations in body weight, we used metabolic chambers to examine energy balance and fuel source utilization. We observed that ovariectomy, but not castration, had profound effects on multiple components of energy balance and altered fuel source utilization (Figure 4A–D). In particular, ovariectomy suppressed food intake, activity, and energy expenditure in both WT and L-RKO mice (Figure 4A,C,D). Ovariectomy also altered fuel source utilization in WT females, with WT OVX mice having a lower RER indicating reduced oxidation of carbohydrates and increased utilization of lipids (Figure 4B). Interesting, L-RKO female mice had a lower RER during the light cycle that was not further suppressed by ovariectomy (Figure 4B).

Figure 4

Download asset Open asset

Gonadectomy alters energy balance and fuel source utilization.

(**A–D**) Metabolic chambers were utilized to determine (A) food consumption, (B) Respiratory exchange ratio (RER), (C) Spontaneous activity, and (D) Energy expenditure in (left) female and (right) male mice lacking hepatic *Rictor* (L-RKO) and their wild-type (WT) littermates of the indicated surgical treatments at 12 months of age. The overall effect of genotype (RKO), gonadectomy (OVX or CAST), and the interaction represent the p-value from a two-way ANOVA conducted separately for the light and dark cycles; *=p < 0.05 from a Holm-Sidak post-test examining the effect of parameters identified as significant in the two-way ANOVA (n = Females, 10 mice/group; Males, WT Sham = 11 mice; WT CAST = 10 mice, L-RKO Sham = 9 mice, L-RKO CAST = 8 mice). Error bars represent SEM.

We next examined how hepatic Rictor loss alters glucose tolerance and insulin sensitivity as the mice age in the presence and absence of gonadal hormones. As we expected based on our previous findings (Lamming et al., 2014a; Lamming et al., 2014b; Lamming et al., 2012), loss of hepatic Rictor had a profound negative effect on glucose tolerance in male mice (Figure 5A and B). Castration did not affect glucose tolerance in either WT or L-RKO mice. We observed no effect of hepatic Rictor deletion on the glucose tolerance of 4 month old female mice (Figure 5C and D), but 11 month old female L-RKO mice had impaired glucose tolerance relative to littermate controls. There was a clear overall negative effect of ovariectomy on glucose tolerance at both ages (Figure 5C and D).

Figure 5 with 2 supplements see all

Download asset Open asset

Independent effects of hepatic *Rictor* deletion and gonadectomy on glucose tolerance and insulin resistance.

(**A–D**) The glucose tolerance of (**A, B**) male and (**C, D**) female mice lacking hepatic *Rictor* (L-RKO) and their wild-type (WT) littermates, of the indicated ages and surgical treatments, was determined following an overnight fast. Area under the curve: the overall effect of genotype (RKO), gonadectomy (OVX or CAST), and the interaction represent the p-value from a two-way ANOVA; *=p < 0.05 from a Holm-Sidak post-test examining the effect of parameters identified as significant in the two-way ANOVA (n = Males: A) 9–12 mice/group, 3–5 months of age; B) 7–12 mice/group, 10–12 months of age. Females: C) 7–11 mice/group, 3–5 months of age; D) 7–11 mice/group, 10–12 months of age). (**E–F**) fasting blood glucose and insulin values were used to calculate HOMA2-IR in E) male and F) female 14 month old mice (n = 4–5 mice/group; the overall effect of genotype (RKO), gonadectomy (OVX or CAST), and the interaction represent the p-value from a two-way ANOVA; *=p < 0.05 from a Holm-Sidak post-test examining the effect of parameters identified as significant in the two-way ANOVA). Error bars represent SEM.

We assessed insulin sensitivity by conducting insulin tolerance tests (ITTs, Figure 5—figure supplement 1) and by determining insulin resistance using homeostasis model assessment (Levy et al., 1998; Figure 5E and F). In males, consistent with impaired hepatic insulin sensitivity, deletion of hepatic Rictor resulted in fasting and glucose-stimulated hyperinsulinemia, and increased HOMA2-IR, despite negligible effects on the response to an ITT (Figure 5E, Figure 5—figure supplements 1–2); castration did not have a significant effect on any of these parameters. In contrast, in female mice genotype did not significantly affect fasting blood glucose or insulin, but ovariectomy did, promoting hyperinsulinemia and increasing HOMA2-IR (Figure 5F). We observed an effect of genotype on female ITT, with young L-RKO mice having a slight impairment of insulin sensitivity, and older ovariectomized L-RKO mice have a statistically significant impairment (Figure 5—figure supplement 1).

Discussion

Here, we tested the role of sex hormones in the sexually dimorphic response to deletion of hepatic Rictor, which we previously observed to preferentially decrease the survival of male mice (Lamming et al., 2014b). We expected that if sex hormones were involved in this response, we would observe one of two possible outcomes: that castration would protect male mice from the loss of hepatic Rictor, or that alternatively, ovariectomy would sensitize female mice to the loss of hepatic Rictor. To our surprise, we observed neither effect; instead, castration failed to protect male L-RKO mice, while ovariectomy had a statistically significant beneficial effect on the midlife survival of female L-RKO mice, and may have had a mild positive effect on wild-type mice as well, increasing the median lifespan.

In contrast to our 2014 study, which found an effect of hepatic Rictor deletion only on male lifespan (Lamming et al., 2014b), here we also observed decreased midlife survival of female L-RKO mice. It is well appreciated that the lifespan of a mouse strain can vary substantially between laboratories (Nadon et al., 2008), and the relatively short lifespan of the wild-type control mice in our 2014 study, which was conducted in a different animal facility, may have obscured this difference. The reason for the decreased overall survival of male L-RKO mice and the decreased survival of female L-RKO mice during midlife is unknown; while our study suggests that this cause of death is not related to cancer, as we performed only a gross necropsy, we cannot at this time rule out the possibility that unobserved neoplasms contribute to these deaths. The mechanism by which ovariectomy protects L-RKO female mice during midlife is also unknown. Future carefully designed studies to assess the organismal health of L-RKO mice, with detailed pathology between 400 and 800 days of age, will be needed to fully address these issues.

The role of sex hormones in the regulation of lifespan has been an active area of investigation for many years. Several studies have shown that early life ablation of the germline extends the lifespan of C. elegans, while ovariectomy extends the lifespan of R. microptera (Arantes-Oliveira et al., 2002; Berman and Kenyon, 2006; Hatle et al., 2013; Iwasa et al., 2018). Although some older studies suggest that ovariectomy decrease the lifespan of rats; at least one of these studies suffers from the lack of a sham surgery control group (Asdell et al., 1967); a more recent study found a small positive effect of ovariectomy on rat lifespan (Iwasa et al., 2018). A recent mouse study found that post-pubertal ovariectomy may shorten mouse lifespan (Benedusi et al., 2015); in contrast, mice in our study were ovariectomized prior to puberty.

Here, we find that pre-pubertal ovariectomy protects the midlife survival of L-RKO mice. Whereas Benedusi and colleagues report a reduction in female lifespan following ovariectomy, we found no statistically significant effect of pre-pubertal ovariectomy on the overall survival of wild-type mice, and in fact observed a small numerical increase (7.4%) in median lifespan. Our findings align with the results of model organism studies which suggest that early life ablation of the female germline promotes survival, and suggest that the control of aging by the female germline is conserved from nematodes and insects to mammals. Critically, the overall positive effects of ovariectomy on longevity do not promote metabolic health, with ovariectomized mice suffering from adiposity and disrupted blood glucose homeostasis, and showing reduced spontaneous activity and energy expenditure. The disruption of metabolic health we observed is in agreement many previous studies showing that ovarian hormones play a critical role in the control of glucose homeostasis in humans and mice (Bailey and Ahmed-Sorour, 1980; Pirimoglu et al., 2011; Stubbins et al., 2012; Yuan et al., 2015).

In contrast, we observed no effect of pre-pubertal castration on mouse lifespan. Our findings differ from results previously reported for rats and humans (Drori and Folman, 1976; Min et al., 2012), but these studies may have been impacted by effects of castration on rodent aggression or confounded by the social status of the castrated humans. Conversely, hormone replacement promotes the survival of men with late onset hypogonadism (Comhaire, 2016). Our results do not support a model in which ablation of the male germline is beneficial for healthspan or longevity. In agreement with recent studies by other groups (Garratt et al., 2017; Harada et al., 2016; Inoue et al., 2010), we observed an effect of castration on weight and body composition, but did not observe an effect of castration on glucose homeostasis.

A limitation of this study is that we did not perform a comprehensive assessment of healthspan (Bellantuono et al., 2020), focusing instead on metabolic parameters. Despite this, it is clear that as in the case of C. elegans, where lifespan and healthspan can be uncoupled (Bansal et al., 2015), pre-pubertal ovariectomy uncouples metabolic health and survival. Scientists around the world are now beginning to focus on geroprotective interventions as a way to prevent or treat age-related diseases. An open question surrounding such interventions has been the effect on health, as while there is a broad consensus in favor of extending healthspan, there is less support for extending lifespan without extending healthspan (Kaeberlein, 2018). Our research here highlights the need to comprehensively assess the effects of geroprotectors on healthspan, as at least some aspects of healthspan are not inextricably coupled to longevity.

Materials and methods

Key resources table

Reagent type (species) or resource	Designation	Source or reference	Identifiers	Additional information
Genetic reagent (Mus. musculus)	C57BL/6J; Rictor^loxP/loxP	David Sabatini Lab (Whitehead Institute for Biomedical Research)	N/A
Genetic reagent (Mus. musculus)	B6.Cg-Speer6- ps1^{Tg(Alb-cre)21Mgn}/J	The Jackson Laboratory	Stock number: 003574; RRID:IMSR_JAX:003574
Genetic reagent (Mus. musculus)	C57BL/6J; Albumin-Cre; Rictor^loxP^/loxP	This paper		See ‘Animal use and care’; Dudley Lamming Lab (UW-Madison)
Drug	Human Insulin	Eli Lilly	NDC 0002-8215-17 (Humulin R U-100)
Commercial assay or kit	Ultra-sensitive mouse insulin ELISA	Crystal Chem	Cat# 90080; RRID:AB_2783626
Software, algorithm	Prism 8	GraphPad Software	N/A
Software, algorithm	R (v. 3.6.0) survival package (v. 2.44)	Therneau, 2015	https://cran.r-project.org/web/packages/survival/index.html
Software, algorithm	HOMA2 Calculator	Levy et al., 1998	https://www.dtu.ox.ac.uk/homacalculator/
Other	Normal Chow	Purina	Cat# 5001

Animal use and care

Request a detailed protocol

All animal procedures conducted at the William S. Middleton Memorial VA Hospital were approved by the Institutional Animal Care and Use Committee of the William S. Middleton Memorial Veterans Hospital (Assurance ID: D16-00403). Mice were multiply housed in microisolator cages and maintained under 12 hr light/dark cycles, and were fed Laboratory Rodent Diet 5001 (LabDiet). Mice hemizygous for Albumin-Cre and homozygous for a floxed allele of Rictor mice were obtained by crossing Rictor^L/L mice on a C57BL/6J background (Lamming et al., 2012), obtained from the Whitehead Institute for Biomedical Research (Cambridge, MA) and rederived by embryo transfer at the UW-Madison Biotechnology Center, with Albumin-Cre mice (The Jackson Laboratory, Stock 003574 Postic et al., 1999).

Body composition

Request a detailed protocol

Body composition was measured by magnetic resonance imaging (EchoMRI, Echo Medical Systems, Houston, USA).

Metabolic chambers

Request a detailed protocol

To assess food intake, RER, spontaneous activity, and energy expenditure by indirect calorimetry, we utilized an Oxymax/CLAMS metabolic chamber system following the manufacturer’s instructions (Columbus Instruments).

Glucose and insulin tolerance tests, glucose-stimulated insulin secretion, and hormone measurements

Request a detailed protocol

Glucose tolerance tests were performed by fasting the mice overnight for 16 hr and then administering glucose (1 g/kg) intraperitoneally (Arriola Apelo et al., 2016b). Insulin tolerance tests were performed by fasting mice overnight for 16 hr, and then injecting 0.75 U/kg human insulin (Eli Lilly) intraperitoneally. Blood glucose was measured periodically for 2 hr after administration of glucose or insulin using a Bayer Contour blood glucose meter and test strips. For glucose-stimulated insulin secretion, mice were fasted overnight for 16 hr, blood glucose levels were determined and plasma was collected immediately prior to and 15 min after administering glucose (1 g/kg) intraperitoneally. Plasma insulin was quantified according to the manufacturer’s protocol using an ultrasensitive mouse insulin ELISA kit (90080) from Crystal Chem. Fasting glucose and insulin levels were then used to calculate HOMA2-IR (Levy et al., 1998).

Surgery

Request a detailed protocol

Mice were gonadectomized or subject to sham surgery during the third week of age. Following anesthesia with isoflurane, mice were shaved and the skin surface was sterilized with betadine and alcohol. For castration (or sham control surgery), a 1.5 cm ventral midline incision was made ending 0.5 cm cranial to the prepuce. In castrated animals, the vas deferens, located along the abdominal fat body on each side, was retrieved using a forceps or hemostat, and the testicle exteriorized. The spermatic artery was then clamped and ligated with 5–0 absorbable suture, and the testis removed. In both castrated and sham control mice, the body wall was closed with 5–0 monofilament absorbable suture, and staples used to close the skin incision. For ovariectomy (or sham control surgery), two 0.5 cm incisions were made through the skin, one on each side (1 cm ventral) to the paralumbar fossa area with its cranial terminus 1.5 cm caudal to the 13th rib, and any fascia trimmed away. Approximately 1 cm ventral to the dorsal spinous processes of the third lumbar vertebra, and immediately caudal to the last rib, the body wall was bluntly dissected through with a mosquito hemostat. For ovariectomy, each ovary was removed as follows; pressure on the abdomen was applied, causing the ovary to be extruded through one of the incisions (if the ovary did not exteriorize, a forceps was inserted to retrieve the ovary) just caudal to the kidney on that side. The ovary was then clamped for 30 s to the level of the fallopian tube, the ovary was removed, and the uterine horn was returned to the body cavity. In both ovariectomized and sham control mice, the muscles on both sides were then sutured with 5–0 absorbable suture, and the skin incisions closed with staples. For pain management, 0.1 mg/kg buprenex was administered IP to the mouse peri-operatively, and every 8–12 hr thereafter (at time of monitoring) as needed. Mice were allowed to recover on a heated pad for up to 1 hr following surgery, and then returned to the home cage. Post-surgery, female mice were provided with moistened breeder chow, and up to 1 mL per day of subcutaneous sterile saline if dehydrated. Staples were removed once healing was complete.

Lifespan and necropsy

Request a detailed protocol

Following surgery, mice that successfully recovered were enrolled in the lifespan study at two months of age. A total of 115 female and 105 male mice were included in the lifespan study, with 23 female and 22 male mice removed for cross sectional analysis. Mice were co-housed (grouped by sex and surgical intervention) in specific pathogen-free housing. Mice were euthanized for humane reasons if moribund, if the mice developed other specified problems (e.g. excessive tumor burden), or upon the recommendation of the facility veterinarian. Mice found dead were noted at each daily inspection and saved in a refrigerator for gross necropsy, during which the abdominal and thoracic cavities were examined for the presence of solid tumors, metastases, splenomegaly, and infection; on the basis of this inspection the presence or absence of observable cancer was recorded.

Statistical analysis

Request a detailed protocol

Data are expressed as mean ± s.e.m. Statistical analysis was conducted using Prism 8 (GraphPad Software), except for survival analyses were conducted in R (version 3.5.0) using the ‘survival’ package (version 2.38) (T, 2015). Cox proportional hazards analysis was performed separately for each sex using genotype and surgical treatment as covariates. Mice which were removed from the study for cross-sectional analysis, and mice for which no record of age of death was available, were censored as of the last day for which a record was available.

Data availability

All data generated or analyzed during this study are included in the manuscript and supporting files.

References

(2002) Regulation of life-span by germ-line stem cells in Caenorhabditis elegans
Science 295:502–505.

https://doi.org/10.1126/science.1065768
- PubMed
- Google Scholar
1. Arriola Apelo SI
2. Neuman JC
3. Baar EL
4. Syed FA
5. Cummings NE
6. Brar HK
7. Pumper CP
8. Kimple ME
9. Lamming DW
(2016a) Alternative rapamycin treatment regimens mitigate the impact of rapamycin on glucose homeostasis and the immune system
Aging Cell 15:28–38.

https://doi.org/10.1111/acel.12405
- PubMed
- Google Scholar
(2016b) Intermittent administration of rapamycin extends the life span of female C57BL/6J mice
The Journals of Gerontology Series A: Biological Sciences and Medical Sciences 71:876–881.

https://doi.org/10.1093/gerona/glw064
- Google Scholar
(1967) The effects of sex steroid hormones upon longevity in rats
Reproduction 14:113–120.

https://doi.org/10.1530/jrf.0.0140113
- Google Scholar
1. Bailey CJ
2. Ahmed-Sorour H
(1980) Role of ovarian hormones in the long-term control of glucose homeostasis effects of insulin secretion
Diabetologia 19:475–481.

https://doi.org/10.1007/BF00281829
- PubMed
- Google Scholar
1. Bansal A
2. Zhu LJ
3. Yen K
4. Tissenbaum HA
(2015) Uncoupling lifespan and healthspan in Caenorhabditis elegans longevity mutants
PNAS 112:E277–E286.

https://doi.org/10.1073/pnas.1412192112
- PubMed
- Google Scholar
(2020) A toolbox for the longitudinal assessment of healthspan in aging mice
Nature Protocols 15:540–574.

https://doi.org/10.1038/s41596-019-0256-1
- PubMed
- Google Scholar
1. Benedusi V
2. Martini E
3. Kallikourdis M
4. Villa A
5. Meda C
6. Maggi A
(2015) Ovariectomy shortens the life span of female mice
Oncotarget 6:10801–10811.

https://doi.org/10.18632/oncotarget.2984
- PubMed
- Google Scholar
1. Berman JR
2. Kenyon C
(2006) Germ-cell loss extends C. elegans life span through regulation of DAF-16 by kri-1 and lipophilic-hormone signaling
Cell 124:1055–1068.

https://doi.org/10.1016/j.cell.2006.01.039
- PubMed
- Google Scholar
1. Bitto A
2. Ito TK
3. Pineda VV
4. LeTexier NJ
5. Huang HZ
6. Sutlief E
7. Tung H
8. Vizzini N
9. Chen B
10. Smith K
11. Meza D
12. Yajima M
13. Beyer RP
14. Kerr KF
15. Davis DJ
16. Gillespie CH
17. Snyder JM
18. Treuting PM
19. Kaeberlein M
(2016) Transient rapamycin treatment can increase lifespan and healthspan in middle-aged mice
eLife 5:e16351.

https://doi.org/10.7554/eLife.16351
- PubMed
- Google Scholar
(2012) Pathobiology of aging mice and GEM: background strains and experimental design
Veterinary Pathology 49:85–105.

https://doi.org/10.1177/0300985811430696
- PubMed
- Google Scholar
1. Chang K
2. Kang P
3. Liu Y
4. Huang K
5. Miao T
6. Sagona AP
7. Nezis IP
8. Bodmer R
9. Ocorr K
10. Bai H
(2019) TGFB-INHB/activin signaling regulates age-dependent autophagy and cardiac health through inhibition of MTORC2
Autophagy 6:1–16.

https://doi.org/10.1080/15548627.2019.1704117
- Google Scholar
1. Chellappa K
2. Brinkman JA
3. Mukherjee S
4. Morrison M
5. Alotaibi MI
6. Carbajal KA
7. Alhadeff AL
8. Perron IJ
9. Yao R
10. Purdy CS
11. DeFelice DM
12. Wakai MH
13. Tomasiewicz J
14. Lin A
15. Meyer E
16. Peng Y
17. Arriola Apelo SI
18. Puglielli L
19. Betley JN
20. Paschos GK
21. Baur JA
22. Lamming DW
(2019) Hypothalamic mTORC2 is essential for metabolic health and longevity
Aging Cell 18:e13014.

https://doi.org/10.1111/acel.13014
- PubMed
- Google Scholar
1. Comhaire F
(2016) Hormone replacement therapy and longevity
Andrologia 48:65–68.

https://doi.org/10.1111/and.12419
- PubMed
- Google Scholar
1. Drori D
2. Folman Y
(1976) Environmental effects on longevity in the male rat: exercise, mating, castration and restricted feeding
Experimental Gerontology 11:25–32.

https://doi.org/10.1016/0531-5565(76)90007-3
- PubMed
- Google Scholar
1. Dumas SN
2. Lamming DW
(2020) Next generation strategies for geroprotection via mTORC1 inhibition
The Journals of Gerontology: Series A 75:14–23.

https://doi.org/10.1093/gerona/glz056
- Google Scholar
1. Garratt M
2. Bower B
3. Garcia GG
4. Miller RA
(2017) Sex differences in lifespan extension with acarbose and 17-α estradiol: gonadal hormones underlie male-specific improvements in glucose tolerance and mTORC2 signaling
Aging Cell 16:1256–1266.

https://doi.org/10.1111/acel.12656
- PubMed
- Google Scholar
1. Garratt M
2. Lagerborg KA
3. Tsai YM
4. Galecki A
5. Jain M
6. Miller RA
(2018) Male lifespan extension with 17-α estradiol is linked to a sex-specific metabolomic response modulated by gonadal hormones in mice
Aging Cell 17:e12786.

https://doi.org/10.1111/acel.12786
- PubMed
- Google Scholar
1. Harada N
2. Hanaoka R
3. Horiuchi H
4. Kitakaze T
5. Mitani T
6. Inui H
7. Yamaji R
(2016) Castration influences intestinal microflora and induces abdominal obesity in high-fat diet-fed mice
Scientific Reports 6:23001.

https://doi.org/10.1038/srep23001
- PubMed
- Google Scholar
1. Harrison DE
2. Strong R
3. Sharp ZD
4. Nelson JF
5. Astle CM
6. Flurkey K
7. Nadon NL
8. Wilkinson JE
9. Frenkel K
10. Carter CS
11. Pahor M
12. Javors MA
13. Fernandez E
14. Miller RA
(2009) Rapamycin fed late in life extends lifespan in genetically heterogeneous mice
Nature 460:392–395.

https://doi.org/10.1038/nature08221
- PubMed
- Google Scholar
1. Hatle JD
2. Kellenberger JW
3. Viray E
4. Smith AM
5. Hahn DA
(2013) Life-extending ovariectomy in grasshoppers increases somatic storage, but dietary restriction with an equivalent feeding rate does not
Experimental Gerontology 48:966–972.

https://doi.org/10.1016/j.exger.2013.06.006
- PubMed
- Google Scholar
1. Inoue T
2. Zakikhani M
3. David S
4. Algire C
5. Blouin MJ
6. Pollak M
(2010) Effects of castration on insulin levels and glucose tolerance in the mouse differ from those in man
The Prostate 70:1628–1635.

https://doi.org/10.1002/pros.21198
- PubMed
- Google Scholar
1. Iwasa T
2. Matsuzaki T
3. Yano K
4. Irahara M
(2018) The effects of ovariectomy and lifelong high-fat diet consumption on body weight, appetite, and lifespan in female rats
Hormones and Behavior 97:25–30.

https://doi.org/10.1016/j.yhbeh.2017.10.005
- PubMed
- Google Scholar
1. Kaeberlein M
2. Powers RW
3. Steffen KK
4. Westman EA
5. Hu D
6. Dang N
7. Kerr EO
8. Kirkland KT
9. Fields S
10. Kennedy BK
(2005) Regulation of yeast replicative life span by TOR and Sch9 in response to nutrients
Science 310:1193–1196.

https://doi.org/10.1126/science.1115535
- PubMed
- Google Scholar
1. Kaeberlein M
(2018) How healthy is the healthspan concept?
GeroScience 40:361–364.

https://doi.org/10.1007/s11357-018-0036-9
- PubMed
- Google Scholar
1. Kapahi P
2. Zid BM
3. Harper T
4. Koslover D
5. Sapin V
6. Benzer S
(2004) Regulation of lifespan in Drosophila by modulation of genes in the TOR signaling pathway
Current Biology 14:885–890.

https://doi.org/10.1016/j.cub.2004.03.059
- PubMed
- Google Scholar
1. Kennedy BK
2. Berger SL
3. Brunet A
4. Campisi J
5. Cuervo AM
6. Epel ES
7. Franceschi C
8. Lithgow GJ
9. Morimoto RI
10. Pessin JE
11. Rando TA
12. Richardson A
13. Schadt EE
14. Wyss-Coray T
15. Sierra F
(2014) Geroscience: linking aging to chronic disease
Cell 159:709–713.

https://doi.org/10.1016/j.cell.2014.10.039
- PubMed
- Google Scholar
1. Kennedy BK
2. Lamming DW
(2016) The mechanistic target of rapamycin: the grand ConducTOR of metabolism and aging
Cell Metabolism 23:990–1003.

https://doi.org/10.1016/j.cmet.2016.05.009
- PubMed
- Google Scholar
1. Kleinert M
2. Sylow L
3. Fazakerley DJ
4. Krycer JR
5. Thomas KC
6. Oxbøll AJ
7. Jordy AB
8. Jensen TE
9. Yang G
10. Schjerling P
11. Kiens B
12. James DE
13. Ruegg MA
14. Richter EA
(2014) Acute mTOR inhibition induces insulin resistance and alters substrate utilization in vivo
Molecular Metabolism 3:630–641.

https://doi.org/10.1016/j.molmet.2014.06.004
- PubMed
- Google Scholar
1. Kleinert M
2. Parker BL
3. Fritzen AM
4. Knudsen JR
5. Jensen TE
6. Kjøbsted R
7. Sylow L
8. Ruegg M
9. James DE
10. Richter EA
(2017) Mammalian target of rapamycin complex 2 regulates muscle glucose uptake during exercise in mice
The Journal of Physiology 595:4845–4855.

https://doi.org/10.1113/JP274203
- PubMed
- Google Scholar
1. Lamming DW
2. Ye L
3. Katajisto P
4. Goncalves MD
5. Saitoh M
6. Stevens DM
7. Davis JG
8. Salmon AB
9. Richardson A
10. Ahima RS
11. Guertin DA
12. Sabatini DM
13. Baur JA
(2012) Rapamycin-induced insulin resistance is mediated by mTORC2 loss and uncoupled from longevity
Science 335:1638–1643.

https://doi.org/10.1126/science.1215135
- PubMed
- Google Scholar
1. Lamming DW
(2014) Diminished mTOR signaling: a common mode of action for endocrine longevity factors
SpringerPlus 3:735.

https://doi.org/10.1186/2193-1801-3-735
- PubMed
- Google Scholar
1. Lamming DW
2. Demirkan G
3. Boylan JM
4. Mihaylova MM
5. Peng T
6. Ferreira J
7. Neretti N
8. Salomon A
9. Sabatini DM
10. Gruppuso PA
(2014a) Hepatic signaling by the mechanistic target of rapamycin complex 2 (mTORC2)
The FASEB Journal 28:300–315.

https://doi.org/10.1096/fj.13-237743
- PubMed
- Google Scholar
1. Lamming DW
2. Mihaylova MM
3. Katajisto P
4. Baar EL
5. Yilmaz OH
6. Hutchins A
7. Gultekin Y
8. Gaither R
9. Sabatini DM
(2014b) Depletion of rictor, an essential protein component of mTORC2, decreases male lifespan
Aging Cell 13:911–917.

https://doi.org/10.1111/acel.12256
- PubMed
- Google Scholar
(1998) Correct homeostasis model assessment (HOMA) evaluation uses the computer program
Diabetes Care 21:2191–2192.

https://doi.org/10.2337/diacare.21.12.2191
- PubMed
- Google Scholar
(2007) MSN2 and MSN4 link calorie restriction and TOR to sirtuin-mediated lifespan extension in Saccharomyces cerevisiae
PLOS Biology 5:e261.

https://doi.org/10.1371/journal.pbio.0050261
- PubMed
- Google Scholar
1. Miller RA
2. Harrison DE
3. Astle CM
4. Fernandez E
5. Flurkey K
6. Han M
7. Javors MA
8. Li X
9. Nadon NL
10. Nelson JF
11. Pletcher S
12. Salmon AB
13. Sharp ZD
14. Van Roekel S
15. Winkleman L
16. Strong R
(2014) Rapamycin-mediated lifespan increase in mice is dose and sex dependent and metabolically distinct from dietary restriction
Aging Cell 13:468–477.

https://doi.org/10.1111/acel.12194
- PubMed
- Google Scholar
1. Min KJ
2. Lee CK
3. Park HN
(2012) The lifespan of korean eunuchs
Current Biology 22:R792–R793.

https://doi.org/10.1016/j.cub.2012.06.036
- PubMed
- Google Scholar
(2014) mTORC2-SGK-1 acts in two environmentally responsive pathways with opposing effects on longevity
Aging Cell 13:869–878.

https://doi.org/10.1111/acel.12248
- PubMed
- Google Scholar
1. Nadon NL
2. Strong R
3. Miller RA
4. Nelson J
5. Javors M
6. Sharp ZD
7. Peralba JM
8. Harrison DE
(2008) Design of aging intervention studies: the NIA interventions testing program
Age 30:187–199.

https://doi.org/10.1007/s11357-008-9048-1
- Google Scholar
1. Pirimoglu ZM
2. Arslan C
3. Buyukbayrak EE
4. Kars B
5. Karsidag YK
6. Unal O
7. Turan MC
(2011) Glucose tolerance of premenopausal women after menopause due to surgical removal of ovaries
Climacteric 14:453–457.

https://doi.org/10.3109/13697137.2010.539723
- PubMed
- Google Scholar
1. Postic C
2. Shiota M
3. Niswender KD
4. Jetton TL
5. Chen Y
6. Moates JM
7. Shelton KD
8. Lindner J
9. Cherrington AD
10. Magnuson MA
(1999) Dual roles for glucokinase in glucose homeostasis as determined by liver and pancreatic beta cell-specific gene knock-outs using cre recombinase
Journal of Biological Chemistry 274:305–315.

https://doi.org/10.1074/jbc.274.1.305
- PubMed
- Google Scholar
(2006) Extension of chronological life span in yeast by decreased TOR pathway signaling
Genes & Development 20:174–184.

https://doi.org/10.1101/gad.1381406
- PubMed
- Google Scholar
(2012) TOR signaling and rapamycin influence longevity by regulating SKN-1/Nrf and DAF-16/FoxO
Cell Metabolism 15:713–724.

https://doi.org/10.1016/j.cmet.2012.04.007
- PubMed
- Google Scholar
1. Sarbassov DD
2. Ali SM
3. Sengupta S
4. Sheen JH
5. Hsu PP
6. Bagley AF
7. Markhard AL
8. Sabatini DM
(2006) Prolonged rapamycin treatment inhibits mTORC2 assembly and akt/PKB
Molecular Cell 22:159–168.

https://doi.org/10.1016/j.molcel.2006.03.029
- PubMed
- Google Scholar
1. Schreiber KH
2. Ortiz D
3. Academia EC
4. Anies AC
5. Liao CY
6. Kennedy BK
(2015) Rapamycin-mediated mTORC2 inhibition is determined by the relative expression of FK506-binding proteins
Aging Cell 14:265–273.

https://doi.org/10.1111/acel.12313
- PubMed
- Google Scholar
1. Schreiber KH
2. Arriola Apelo SI
3. Yu D
4. Brinkman JA
5. Velarde MC
6. Syed FA
7. Liao CY
8. Baar EL
9. Carbajal KA
10. Sherman DS
11. Ortiz D
12. Brunauer R
13. Yang SE
14. Tzannis ST
15. Kennedy BK
16. Lamming DW
(2019) A novel rapamycin analog is highly selective for mTORC1 in vivo
Nature Communications 10:3194.

https://doi.org/10.1038/s41467-019-11174-0
- PubMed
- Google Scholar
1. Soukas AA
2. Kane EA
3. Carr CE
4. Melo JA
5. Ruvkun G
(2009) Rictor/TORC2 regulates fat metabolism, feeding, growth, and life span in Caenorhabditis elegans
Genes & Development 23:496–511.

https://doi.org/10.1101/gad.1775409
- PubMed
- Google Scholar
(2012) Estrogen modulates abdominal adiposity and protects female mice from obesity and impaired glucose tolerance
European Journal of Nutrition 51:861–870.

https://doi.org/10.1007/s00394-011-0266-4
- PubMed
- Google Scholar
Software
1. Therneau TM
(2015) A Package for Survival Analysis in S, version 2.38
CRAN.

https://CRAN.R-project.org/package=survival
1. Vellai T
2. Takacs-Vellai K
3. Zhang Y
4. Kovacs AL
5. Orosz L
6. Müller F
(2003) Genetics: influence of TOR kinase on lifespan in C. elegans
Nature 426:620.

https://doi.org/10.1038/426620a
- PubMed
- Google Scholar
1. Yu D
2. Tomasiewicz JL
3. Yang SE
4. Miller BR
5. Wakai MH
6. Sherman DS
7. Cummings NE
8. Baar EL
9. Brinkman JA
10. Syed FA
11. Lamming DW
(2019) Calorie-Restriction-Induced insulin sensitivity is mediated by adipose mTORC2 and not required for lifespan extension
Cell Reports 29:236–248.

https://doi.org/10.1016/j.celrep.2019.08.084
- PubMed
- Google Scholar
1. Yuan T
2. Li J
3. Zhao WG
4. Fu Y
5. Liu SN
6. Liu Q
7. Shen ZF
(2015) Effects of estrogen on insulin sensitivity and adipokines in mice
Zhongguo Yi Xue Ke Xue Yuan Xue Bao. Acta Academiae Medicinae Sinicae 37:269–273.

https://doi.org/10.3881/j.issn.1000-503X.2015.03.004
- PubMed
- Google Scholar

Article and author information

Author details

Sebastian I Arriola Apelo
1. Department of Dairy Science, University of Wisconsin-Madison, Madison, United States
2. William S. Middleton Memorial Veterans Hospital, Madison, United States
3. Department of Medicine, University of Wisconsin-Madison, Madison, United States
Contribution
Formal analysis, Supervision, Investigation, Writing - review and editing

Competing interests
No competing interests declared
Amy Lin
1. Department of Dairy Science, University of Wisconsin-Madison, Madison, United States
2. William S. Middleton Memorial Veterans Hospital, Madison, United States
3. Department of Medicine, University of Wisconsin-Madison, Madison, United States
Contribution
Investigation

Competing interests
No competing interests declared
Jacqueline A Brinkman
1. William S. Middleton Memorial Veterans Hospital, Madison, United States
2. Department of Medicine, University of Wisconsin-Madison, Madison, United States
Contribution
Investigation

Competing interests
No competing interests declared
Emma Meyer
1. Department of Dairy Science, University of Wisconsin-Madison, Madison, United States
2. William S. Middleton Memorial Veterans Hospital, Madison, United States
3. Department of Medicine, University of Wisconsin-Madison, Madison, United States
Contribution
Investigation

Competing interests
No competing interests declared
Mark Morrison
1. William S. Middleton Memorial Veterans Hospital, Madison, United States
2. Department of Medicine, University of Wisconsin-Madison, Madison, United States
Contribution
Investigation

Competing interests
No competing interests declared
Jay L Tomasiewicz

William S. Middleton Memorial Veterans Hospital, Madison, United States

Contribution
Investigation

Competing interests
No competing interests declared
Cassidy P Pumper
1. William S. Middleton Memorial Veterans Hospital, Madison, United States
2. Department of Medicine, University of Wisconsin-Madison, Madison, United States
Contribution
Investigation

Competing interests
No competing interests declared
Emma L Baar
1. William S. Middleton Memorial Veterans Hospital, Madison, United States
2. Department of Medicine, University of Wisconsin-Madison, Madison, United States
Contribution
Investigation

Competing interests
No competing interests declared
Nicole E Richardson
1. William S. Middleton Memorial Veterans Hospital, Madison, United States
2. Department of Medicine, University of Wisconsin-Madison, Madison, United States
3. Endocrinology and Reproductive Physiology Graduate Training Program, University of Wisconsin-Madison, Madison, United States
Contribution
Investigation

Competing interests
No competing interests declared
Mohammed Alotaibi
1. William S. Middleton Memorial Veterans Hospital, Madison, United States
2. Department of Medicine, University of Wisconsin-Madison, Madison, United States
3. Endocrinology and Reproductive Physiology Graduate Training Program, University of Wisconsin-Madison, Madison, United States
Contribution
Investigation

Competing interests
No competing interests declared
Dudley W Lamming
1. William S. Middleton Memorial Veterans Hospital, Madison, United States
2. Department of Medicine, University of Wisconsin-Madison, Madison, United States
3. Endocrinology and Reproductive Physiology Graduate Training Program, University of Wisconsin-Madison, Madison, United States
4. University of Wisconsin Carbone Comprehensive Cancer Center, University of Wisconsin, Madison, United States
Contribution
Conceptualization, Resources, Formal analysis, Supervision, Funding acquisition, Writing - original draft, Project administration, Writing - review and editing

For correspondence
dlamming@medicine.wisc.edu

Competing interests
DWL has received funding from, and is a scientific advisory board member of, Aeovian Pharmaceuticals, which seeks to develop novel, selective mTOR inhibitors for the treatment of various diseases.

"This ORCID iD identifies the author of this article:" 0000-0002-0079-4467

Funding

American Federation for Aging Research

Dudley W Lamming

National Institute on Aging (AG041765)

Nicole E Richardson
Dudley W Lamming

American Diabetes Association (1-16-PMF-001)

Sebastian I Arriola Apelo

National Center for Advancing Translational Sciences (UL1TR002373)

Dudley W Lamming

Glenn Foundation for Medical Research

Dudley W Lamming

U.S. Department of Veterans Affairs (I01-BX004031)

Dudley W Lamming

National Institute on Aging (AG050135)

Nicole E Richardson
Dudley W Lamming

National Institute on Aging (AG051974)

Nicole E Richardson
Dudley W Lamming

National Institute on Aging (AG056771)

Nicole E Richardson
Dudley W Lamming

National Institute on Aging (AG062328)

Nicole E Richardson
Dudley W Lamming

National Institute on Aging (AG000213)

Nicole E Richardson

School of Medicine and Public Health, University of Wisconsin-Madison

Dudley W Lamming

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Acknowledgements

We thank Dr. Abigail Radcliff for advice on animal surgery and the University of Wisconsin-Madison Biotechnology Center Transgenic Animal Facility for rederivation services. We thank A Broman of the UW-Madison Department of Biostatistics and Medical Informatics for assistance with analysis of lifespan data and R. We thank Dr. Joseph Baur and Dr. Maria Mihaylova for critical reading of the manuscript, and Dr. Dena Cohen for support and encouragement. This research was supported in part by an American Federation for Aging Research Junior Faculty Research Grant to DWL. Additional research support was provided by the National Institute of Health/National Institute on Aging (AG041765, AG050135, AG051974, AG056771, AG062328), a Glenn Foundation Award for Research in the Biological Mechanisms of Aging to DWL and funds from the University of Wisconsin-Madison School of Medicine and Public Health and Department of Medicine to DWL. SIAA was supported in part by a fellowship from the American Diabetes Association (1–16-PMF-001). NER was supported in part by a training grant from the UW Institute on Aging (NIA T32 AG000213). The project was supported by the Clinical and Translational Science Award (CTSA) program, through the NIH National Center for Advancing Translational Sciences (NCATS), grant UL1TR002373. The Lamming laboratory is supported in part by the U.S. Department of Veterans Affairs (I01-BX004031), and this work was supported using facilities and resources from the William S Middleton Memorial Veterans Hospital. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. This work does not represent the views of the Department of Veterans Affairs or the United States Government.

Ethics

Animal experimentation: All animal procedures conducted at the William S. Middleton Memorial VA Hospital were approved by the Institutional Animal Care and Use Committee of the William S. Middleton Memorial Veterans Hospital. (Assurance ID: D16-00403).

Copyright

This is an open-access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the Creative Commons CC0 public domain dedication.